A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)
The project is a commercial clinical trial testing the effectiveness of a new antidepressant treatment in reducing symptoms in individuals with MDD.